IRIS Accounts Production v24.2.0.383 12496921 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false Ordinary A Shares 1.00000 Ordinary B Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh124969212023-03-31124969212024-03-31124969212023-04-012024-03-31124969212022-03-31124969212022-04-012023-03-31124969212023-03-3112496921ns15:EnglandWales2023-04-012024-03-3112496921ns14:PoundSterling2023-04-012024-03-3112496921ns10:Director12023-04-012024-03-3112496921ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3112496921ns10:SmallEntities2023-04-012024-03-3112496921ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112496921ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3112496921ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3112496921ns10:FullAccounts2023-04-012024-03-311249692112023-04-012024-03-3112496921ns10:OrdinaryShareClass12023-04-012024-03-3112496921ns10:OrdinaryShareClass22023-04-012024-03-3112496921ns10:Director22023-04-012024-03-3112496921ns10:RegisteredOffice2023-04-012024-03-3112496921ns5:CurrentFinancialInstruments2024-03-3112496921ns5:CurrentFinancialInstruments2023-03-3112496921ns5:ShareCapital2024-03-3112496921ns5:ShareCapital2023-03-3112496921ns5:RetainedEarningsAccumulatedLosses2024-03-3112496921ns5:RetainedEarningsAccumulatedLosses2023-03-3112496921ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112496921ns5:NetGoodwill2023-03-3112496921ns5:NetGoodwill2023-04-012024-03-3112496921ns5:NetGoodwill2024-03-3112496921ns5:NetGoodwill2023-03-3112496921ns5:FurnitureFittings2023-03-3112496921ns5:MotorVehicles2023-03-3112496921ns5:ComputerEquipment2023-03-3112496921ns5:FurnitureFittings2023-04-012024-03-3112496921ns5:MotorVehicles2023-04-012024-03-3112496921ns5:ComputerEquipment2023-04-012024-03-3112496921ns5:FurnitureFittings2024-03-3112496921ns5:MotorVehicles2024-03-3112496921ns5:ComputerEquipment2024-03-3112496921ns5:FurnitureFittings2023-03-3112496921ns5:MotorVehicles2023-03-3112496921ns5:ComputerEquipment2023-03-3112496921ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3112496921ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3112496921ns10:OrdinaryShareClass12024-03-3112496921ns10:OrdinaryShareClass22024-03-31124969211ns10:Director12023-03-31124969211ns10:Director12022-03-31124969211ns10:Director12023-04-012024-03-31124969211ns10:Director12022-04-012023-03-31124969211ns10:Director12024-03-31124969211ns10:Director12023-03-31
REGISTERED NUMBER: 12496921 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED

MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 12496921)

CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2024







DIRECTORS: Mr M A Mokawem
Mrs J E Mokawem





REGISTERED OFFICE: Royal National Orthopaedic Hospital
Brockley Hill
Stanmore
Middlesex
HA7 4LP





REGISTERED NUMBER: 12496921 (England and Wales)





ACCOUNTANTS: Xeinadin
100 Barbirolli Square
Manchester
M2 3BD

MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 12496921)

BALANCE SHEET
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 2,400 4,800
Tangible assets 5 30,993 41,423
33,393 46,223

CURRENT ASSETS
Debtors 6 8,231 6,238
Cash at bank 63,386 73,529
71,617 79,767
CREDITORS
Amounts falling due within one year 7 10,143 11,453
NET CURRENT ASSETS 61,474 68,314
TOTAL ASSETS LESS CURRENT
LIABILITIES

94,867

114,537

PROVISIONS FOR LIABILITIES 7,748 10,356
NET ASSETS 87,119 104,181

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 87,019 104,081
SHAREHOLDERS' FUNDS 87,119 104,181

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 12496921)

BALANCE SHEET - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 November 2024 and were signed on its behalf by:





Mr M A Mokawem - Director


MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 12496921)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

Michael Mokawem Medical Practice Limited is a private company, limited by shares, registered in England and Wales, registration number 12496921. The address of the registered office and principal place of business is Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, HA7 4LP.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts in respect of the provision of medical services provided to individuals and is recognised as the service is provided. Turnover is exclusive of value added tax where applicable.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Goodwill is being amortised evenly over its estimated useful life of five years.

Tangible fixed assets
Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

Depreciation on tangible fixed assets is charged to the profit and loss so as to write off their value, over their estimated useful lives, using the following methods:


Computer Equipment-25% Straight Line
Motor vehicles-25% Reducing Balance
Fixture and fittings-20% Straight Line

At each balance sheet date, the Company reviews the carrying amounts of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. Impairment loss is recognised as an expense immediately.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 12496921)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases, the receivables are stated at cost less impairment losses for bad and doubtful debts.

Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method unless the effect of discounting would be immaterial, in which case they are stated at cost.

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 12,000
AMORTISATION
At 1 April 2023 7,200
Charge for year 2,400
At 31 March 2024 9,600
NET BOOK VALUE
At 31 March 2024 2,400
At 31 March 2023 4,800

MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 12496921)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024


5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2023 7,263 65,506 874 73,643
Additions - - 518 518
At 31 March 2024 7,263 65,506 1,392 74,161
DEPRECIATION
At 1 April 2023 2,905 28,659 656 32,220
Charge for year 1,453 9,212 283 10,948
At 31 March 2024 4,358 37,871 939 43,168
NET BOOK VALUE
At 31 March 2024 2,905 27,635 453 30,993
At 31 March 2023 4,358 36,847 218 41,423

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 7,349 6,238
Directors' current accounts 882 -
8,231 6,238

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 7,236 7,935
Directors' current accounts - 62
Accrued expenses 2,907 3,456
10,143 11,453

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
50 Ordinary A Shares £1.00 50 50
50 Ordinary B Shares £1.00 50 50
100 100

MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED (REGISTERED NUMBER: 12496921)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024


9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Mr M A Mokawem
Balance outstanding at start of year 62 3,000
Amounts advanced (744 ) -
Amounts repaid - (2,938 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (682 ) 62